A study to assess anti-obesity medication use in commercial health insurances in the United States
Latest Information Update: 23 Jul 2021
At a glance
- Drugs Liraglutide (Primary) ; Naltrexone/bupropion (Primary) ; Phentermine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 23 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Diabetes, Obesity and Metabolism.